重症监护室获得性无力、膈肌功能障碍与危重患者长期结局
本研究为观察性队列的辅助研究,在患者首次自主呼吸试验时纳入机械通气患者,以膈神经刺激产生的气管压力<11 cmH2O定义膈肌功能障碍,以医学研究委员会(MRC)评分<48定义ICU获得性无力。69例患者纳入生存分析,40例完成SF-36生活质量访谈。ICU获得性无力组2年生存率46%(11/24),无ICU获得性无力组76%(34/45);膈肌功能障碍组64%(29/45),无膈肌功能障碍组71%(17/24)。膈肌功能障碍与ICU获得性无力共存者2年生存率36%(5/14),低于两者均无者79%(11/14)(p<0.01)。健康相关生活质量不受ICU获得性无力、膈肌功能障碍或其共存影响。
要点
- ICU获得性无力(MRC评分<48)者2年生存率46%(11/24),无ICU获得性无力者76%(34/45)。
- 膈肌功能障碍(膈神经刺激气管压力<11 cmH2O)者2年生存率64%(29/45),无膈肌功能障碍者71%(17/24)。
- 膈肌功能障碍与ICU获得性无力共存者2年生存率36%(5/14),低于两者均无者79%(11/14)(p<0.01)。
- 健康相关生活质量(SF-36)不受ICU获得性无力、膈肌功能障碍或其共存影响。
- 结论:ICU获得性无力而非膈肌功能障碍与危重患者2年生存率差相关。
适用人群与场景
- 机械通气患者,在首次自主呼吸试验时纳入。
- 本研究为观察性队列研究的辅助研究,76例患者中69例纳入生存分析、40例完成生活质量访谈。
诊断标准与关键阈值
- 膈肌功能障碍:膈神经刺激产生的气管压力<11 cmH2O。
- ICU获得性无力:医学研究委员会(MRC)评分<48。
研究设计与关键结果
- 研究类型:观察性队列研究的辅助研究;69例纳入生存分析,40例完成SF-36生活质量访谈。
- 2年总生存率67%(46/69);膈肌功能障碍组64%(29/45) vs 无膈肌功能障碍组71%(17/24);ICU获得性无力组46%(11/24) vs 无ICU获得性无力组76%(34/45)。
- 膈肌功能障碍与ICU获得性无力共存者2年生存率36%(5/14),低于两者均无者79%(11/14)(p<0.01)。
- 健康相关生活质量(SF-36)不受ICU获得性无力、膈肌功能障碍或其共存影响。
证据类型、等级与局限
- 证据类型:观察性队列研究的辅助研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为:ICU获得性无力而非膈肌功能障碍与危重患者2年生存率差相关。
- 作者认为:膈肌功能障碍与ICU获得性无力共存时2年生存率更差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intensive care unit (ICU)-acquired weakness and diaphragm dysfunction are frequent conditions, both associated with poor prognosis in critically ill patients. While it is well established that ICU-acquired weakness severely impairs long-term prognosis, the association of diaphragm dysfunction with this outcome has never been reported. This study investigated whether diaphragm dysfunction is associated with negative long-term outcomes and whether the coexistence of diaphragm dysfunction and ICU-acquired weakness has a particular association with 2-year survival and health-related quality of life (HRQOL).
METHODS: This study is an ancillary study derived from an observational cohort study. Patients under mechanical ventilation were enrolled at the time of their first spontaneous breathing trial. Diaphragm dysfunction was defined by tracheal pressure generated by phrenic nerve stimulation < 11 cmH2O and ICU-acquired weakness was defined by Medical Research Council (MRC) score < 48. HRQOL was evaluated with the SF-36 questionnaire.
RESULTS: Sixty-nine of the 76 patients enrolled in the original study were included in the survival analysis and 40 were interviewed. Overall 2-year survival was 67% (46/69): 64% (29/45) in patients with diaphragm dysfunction, 71% (17/24) in patients without diaphragm dysfunction, 46% (11/24) in patients with ICU-acquired weakness and 76% (34/45) in patients without ICU-acquired weakness. Patients with concomitant diaphragm dysfunction and ICU-acquired weakness had a poorer outcome with a 2-year survival rate of 36% (5/14) compared to patients without diaphragm function and ICU-acquired weakness [79% (11/14) (p < 0.01)]. Health-related quality of life was not influenced by the presence of ICU-acquired weakness, diaphragm dysfunction or their coexistence.
CONCLUSIONS: ICU-acquired weakness but not diaphragm dysfunction was associated with a poor 2-year survival of critically ill patients.
参考来源
- Saccheri C, Morawiec E, Delemazure J, et al. ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients. Ann Intensive Care. 2020. PMID: 31900667. doi:10.1186/s13613-019-0618-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。